Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression-Reference-Cited by-同舟云学术

Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression

Published:2008-01-29 Issue:3 Volume:5 Page:158-168
ISSN:1743-4297
Container-title:Nature Clinical Practice Cardiovascular Medicine
language:en
Short-container-title:Nat Rev Cardiol

Author:

Keren Andre,Syrris Petros,McKenna William J

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.nature.com/articles/ncpcardio1110.pdf

Reference79 articles.

1. Richardson P et al. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93: 841–842

2. Maron BJ et al. (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4,111 subjects in the CARDIA study (Coronary Artery Risk Development in [Young] Adults). Circulation 92: 785–789

3. Goldstein JL (2001) Familial hypercholesterolemia. In: The Metabolic and Molecular Bases of Inherited Diseases, edn 8, 2863–2913 (Eds Scriver CS. et al.) New York, NY: McGraw-Hill Book Co

4. Soutar AK and Naoumova RP (2007) Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med 4: 214–225

5. McKenna WJ et al. (1997) Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 77: 130–132

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Prevalence of Cardiac Surgery–associated Acute Kidney Injury After Septal Myectomy Combined With Concomitant Procedures in Obstructive Hypertrophic Cardiomyopathy;Journal of Cardiothoracic and Vascular Anesthesia;2024-10

2. Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathy;International Journal of Cardiology;2024-09

3. Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correction;Cell Reports Medicine;2024-05

4. The Role of Genetics in Cardiomyopathy;Pediatric Cardiology;2024

5. RISK CLASSIFICATION FOR SUDDEN CARDIAC DEATH IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY BASED ON MACHINE LEARNING ALGORITHMS;Journal of the Serbian Society for Computational Mechanics;2023-12-01